Reporter April 6 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

Close up on the left eye of a black man

Aqueous humor, microRNAs and glaucoma

New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy.

New view of the heartbeat

Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.

Karp to succeed Beauchamp as Surgical Section leader

After successfully leading Vanderbilt University Medical Center’s Section of Surgical Sciences and serving as the Medical Center’s Surgeon-in-Chief since 2001, R. Daniel Beauchamp, MD, the John Clinton Foshee Distinguished Professor of Surgery, is stepping down. Beauchamp will be succeeded in this role by Seth Karp, MD, H. William Scott Jr. Professor and chair of the Department of Surgery and director of the Vanderbilt Transplant Center.

Change positions Department of Urologic Surgery for sustained growth

Beginning July 1, Vanderbilt University Medical Center’s Department of Urologic Surgery, which is currently housed within the Medical Center’s Section of Surgical Sciences, will become an independent department.

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

1 2